BiomX Discloses Acne Pre-clinical Data Planned for 2020 AAD Annual Meeting
BiomX Inc. COmmon Stock (PHGE)
Company Research
Source: Business Wire
NESS ZIONA, Israel--(BUSINESS WIRE)--BiomX Inc. (NYSE: PHGE), a microbiome company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today disclosed pre-clinical data from its acne program, originally planned to be presented at the Annual Meeting of the American Academy of Dermatology (AAD) on March 20, 2020 before the conference was canceled due to ongoing COVID-19 pandemic concerns. The pre-clinical data can be found on the AAD’s website as well as the Company’s website.BiomX is developing BX001, its lead product candidate, to modify the appearance of acne prone skin. BX001 is a topically administered gel comprised of a cocktail of naturally occurring phage targeting Cutibacterium acnes (C. acnes), a bacterium implicated in the pathophysiology of acne vulgaris. The pre-clinical data disclosed include in vitro results demonstrating BX001’s activity against C. acnes, including antibiotic resistant clinical isolates of C. acnes, and BX
Show less
Read more
Impact Snapshot
Event Time:
PHGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHGE alerts
High impacting BiomX Inc. COmmon Stock news events
Weekly update
A roundup of the hottest topics
PHGE
News
- BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards [Yahoo! Finance]Yahoo! Finance
- BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing StandardsGlobeNewswire
- Microbiome Sequencing Services Business Report 2024-2030: Strong Investment in Genomics Research Crucial for Market Growth [Yahoo! Finance]Yahoo! Finance
- Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI [Yahoo! Finance]Yahoo! Finance
- BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising Expenses [Yahoo! Finance]Yahoo! Finance
PHGE
Earnings
- 11/14/24 - Beat
PHGE
Sec Filings
- 12/16/24 - Form 8-K
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- PHGE's page on the SEC website